| Literature DB >> 23054490 |
Carlos K H Wong1, Cindy L K Lam, Brendan Mulhern, Wai-Lun Law, Jensen T C Poon, Dora L W Kwong, Janice Tsang.
Abstract
OBJECTIVES: To test for the measurement invariance of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) in patients with colorectal neoplasms between two modes of administration (self- and interviewer administrations). It is important to establish the measurement invariance of the FACT-C across different modes of administration to ascertain whether it is valid to pool FACT-C data collected by different modes or to assess each group separately.Entities:
Mesh:
Year: 2012 PMID: 23054490 PMCID: PMC3731518 DOI: 10.1007/s11136-012-0272-x
Source DB: PubMed Journal: Qual Life Res ISSN: 0962-9343 Impact factor: 4.147
Socio-demographic characteristics of study subjects by mode of administration and by completion of FACT-C instrument
| Self ( | Interview ( | Complete | Incomplete | |||
|---|---|---|---|---|---|---|
| Total ( |
| Total ( |
| |||
| Age (year, mean ± SD)†‡ | 61.2 ± 10.8 | 66.0 ± 12.0 | 63.1 ± 11.5 | <0.001 | 65.9 ± 9.8 | 0.009 |
| Sex (%) | 0.697 | 0.098 | ||||
| Male | 59.6 | 61.5 | 60.4 | 52.4 | ||
| Female | 40.4 | 38.5 | 39.6 | 47.6 | ||
| Education level (%)† | <0.001 | 0.102 | ||||
| No formal school | 7.2 | 17.3 | 11.3 | 10.4 | ||
| Primary | 28.9 | 37.8 | 32.5 | 42.4 | ||
| Secondary | 45.5 | 36.5 | 41.9 | 38.9 | ||
| Tertiary | 18.3 | 8.3 | 14.3 | 8.3 | ||
| Marital status (%)‡ | 0.431 | <0.001 | ||||
| Married | 82.1 | 78.8 | 80.8 | 60.0 | ||
| Not married | 17.9 | 21.2 | 19.2 | 40.0 | ||
| Currently working (%)† | 0.001 | 0.183 | ||||
| Yes | 28.9 | 14.7 | 23.3 | 17.9 | ||
| No | 71.1 | 85.3 | 76.7 | 82.1 | ||
| Income (HKD, %)†‡ | <0.001 | <0.001 | ||||
| ≤$20,000 | 72.6 | 92.9 | 80.7 | 94.3 | ||
| >$20,000 | 27.4 | 7.1 | 19.3 | 5.7 | ||
| Smoking (%) | 0.366 | 0.194 | ||||
| Ever had | 26.0 | 30.1 | 27.6 | 22.1 | ||
| Never had | 74.0 | 69.9 | 72.4 | 77.9 | ||
| Drinking (%) | 0.326 | 0.436 | ||||
| Ever had | 30.2 | 25.6 | 28.4 | 25.0 | ||
| Never had | 69.8 | 74.4 | 71.6 | 75.0 | ||
| Colorectal neoplasm (%)†‡ | 0.041 | 0.049 | ||||
| CRC | 70.2 | 79.5 | 73.9 | 82.1 | ||
| Polyps | 29.8 | 20.5 | 26.1 | 17.9 | ||
| Active CRC treatment (%)*† |
|
|
| 0.007 |
| 0.403 |
| No | 77.6 | 71.8 | 75.1 | 79.8 | ||
| Adjuvant | 10.3 | 4.0 | 7.6 | 4.2 | ||
| Palliative | 12.1 | 24.2 | 17.3 | 16.0 | ||
| Stoma (%)*† |
|
|
| 0.045 |
| 0.456 |
| Present | 9.7 | 17.7 | 13.1 | 16.0 | ||
| Absent | 90.3 | 82.3 | 86.9 | 84.0 | ||
CRC colorectal cancer
* Colorectal cancer (CRC) group only
†Significant difference between modes of administration by chi-square or independent t test
‡Significant difference between subjects completing and not completing FACT-C by chi-square or independent t test
Descriptive statistics of 33 items of the FACT-C among two modes of administration
| Item | Interview ( | Self ( | Total ( |
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean | SD | Floor % | Ceiling % | Mean | SD | Floor % | Ceiling % | Mean | SD | Floor % | Ceiling % | ||
| PWB† | 25.36 | 3.31 | 23.06 | 4.95 | 23.97 | 4.51 | <0.001 | ||||||
| GP1† | 0.59 | 0.91 | 63 | 1 | 1.00 | 1.11 | 43 | 3 | 0.84 | 1.05 | 51 | 2 | <0.001 |
| GP2† | 0.12 | 0.39 | 90 | 0 | 0.42 | 0.80 | 74 | 0 | 0.30 | 0.68 | 81 | 0 | <0.001 |
| GP3† | 0.12 | 0.45 | 92 | 0 | 0.73 | 1.00 | 55 | 3 | 0.48 | 0.88 | 70 | 2 | <0.001 |
| GP4† | 0.51 | 0.85 | 69 | 0 | 0.72 | 0.89 | 51 | 1 | 0.64 | 0.88 | 58 | 1 | 0.020 |
| GP5† | 0.33 | 0.81 | 82 | 1 | 0.83 | 1.09 | 55 | 3 | 0.63 | 1.02 | 66 | 2 | <0.001 |
| GP6† | 0.64 | 0.92 | 60 | 1 | 0.84 | 0.98 | 48 | 1 | 0.76 | 0.96 | 52 | 1 | 0.042 |
| GP7 | 0.33 | 0.76 | 79 | 0 | 0.41 | 0.84 | 76 | 0 | 0.38 | 0.81 | 77 | 0 | 0.368 |
| SWB | 19.89 | 4.72 | 20.05 | 6.14 | 19.99 | 5.61 | 0.776 | ||||||
| GS1* | 2.46 | 1.04 | 8 | 12 | 2.61 | 1.13 | 6 | 23 | 2.55 | 1.09 | 7 | 18 | 0.194 |
| GS2* | 3.03 | 0.84 | 3 | 26 | 3.09 | 0.99 | 2 | 40 | 3.06 | 0.93 | 2 | 35 | 0.582 |
| GS3* | 2.60 | 1.06 | 8 | 15 | 2.72 | 1.13 | 4 | 27 | 2.67 | 1.10 | 6 | 22 | 0.263 |
| GS4* | 3.13 | 0.75 | 2 | 28 | 3.23 | 0.99 | 3 | 50 | 3.19 | 0.90 | 2 | 41 | 0.330 |
| GS5* | 3.06 | 0.87 | 3 | 28 | 3.13 | 0.97 | 3 | 41 | 3.10 | 0.93 | 3 | 36 | 0.466 |
| GS6* | 2.97 | 0.96 | 5 | 28 | 3.05 | 1.10 | 5 | 42 | 3.02 | 1.05 | 5 | 36 | 0.479 |
| EWB† | 21.12 | 3.15 | 18.73 | 4.66 | 19.68 | 4.29 | <0.001 | ||||||
| GE1† | 0.38 | 0.78 | 76 | 0 | 0.75 | 0.99 | 54 | 2 | 0.61 | 0.93 | 63 | 1 | <0.001 |
| GE2*† | 3.05 | 0.84 | 3 | 28 | 2.74 | 1.13 | 6 | 28 | 2.87 | 1.03 | 5 | 28 | 0.004 |
| GE3† | 0.26 | 0.74 | 86 | 1 | 0.43 | 0.79 | 71 | 1 | 0.37 | 0.78 | 77 | 1 | 0.032 |
| GE4† | 0.32 | 0.68 | 78 | 0 | 0.89 | 1.05 | 44 | 4 | 0.66 | 0.96 | 58 | 2 | <0.001 |
| GE5† | 0.27 | 0.70 | 84 | 1 | 0.74 | 1.01 | 57 | 3 | 0.55 | 0.93 | 68 | 2 | <0.001 |
| GE6† | 0.69 | 0.99 | 61 | 1 | 1.20 | 1.18 | 35 | 6 | 0.99 | 1.13 | 45 | 4 | <0.001 |
| FWB | 18.87 | 4.73 | 18.54 | 6.47 | 18.67 | 5.83 | 0.583 | ||||||
| GF1*† | 2.27 | 1.27 | 13 | 17 | 2.63 | 1.17 | 8 | 26 | 2.49 | 1.22 | 10 | 23 | 0.004 |
| GF2* | 2.81 | 0.96 | 4 | 21 | 2.63 | 1.16 | 6 | 25 | 2.71 | 1.09 | 6 | 23 | 0.109 |
| GF3* | 2.76 | 0.81 | 3 | 12 | 2.73 | 1.10 | 4 | 27 | 2.74 | 1.00 | 3 | 21 | 0.812 |
| GF4*† | 3.16 | 0.70 | 2 | 28 | 2.80 | 1.03 | 4 | 26 | 2.94 | 0.93 | 3 | 27 | <0.001 |
| GF5* | 2.45 | 1.04 | 6 | 13 | 2.41 | 1.15 | 8 | 18 | 2.43 | 1.11 | 7 | 16 | 0.754 |
| GF6* | 2.57 | 1.05 | 7 | 15 | 2.65 | 1.11 | 6 | 24 | 2.62 | 1.08 | 6 | 20 | 0.496 |
| GF7* | 2.85 | 0.82 | 3 | 17 | 2.69 | 1.09 | 4 | 25 | 2.75 | 0.99 | 4 | 21 | 0.112 |
| CCS† | 21.78 | 3.61 | 20.10 | 5.05 | 20.77 | 4.60 | <0.001 | ||||||
| C1† | 0.36 | 0.73 | 76 | 0 | 0.76 | 0.93 | 51 | 1 | 0.60 | 0.88 | 61 | 1 | <0.001 |
| C2 | 0.32 | 0.70 | 78 | 1 | 0.44 | 0.81 | 71 | 1 | 0.39 | 0.77 | 74 | 1 | 0.139 |
| C3* | 2.51 | 1.17 | 11 | 17 | 2.28 | 1.35 | 16 | 20 | 2.37 | 1.28 | 14 | 19 | 0.075 |
| C4* | 2.77 | 0.88 | 3 | 15 | 2.58 | 1.10 | 6 | 20 | 2.65 | 1.02 | 5 | 18 | 0.071 |
| C5† | 0.36 | 0.67 | 74 | 0 | 0.71 | 1.00 | 57 | 2 | 0.57 | 0.90 | 64 | 1 | <0.001 |
| C6* | 2.80 | 0.84 | 2 | 16 | 2.71 | 1.18 | 6 | 29 | 2.75 | 1.06 | 5 | 24 | 0.408 |
| C7*† | 2.73 | 0.95 | 4 | 19 | 2.44 | 1.18 | 9 | 20 | 2.56 | 1.11 | 7 | 20 | 0.011 |
* Higher item scores indicate better HRQOL; for other items, higher scores indicate worse HRQOL
†Significant difference between interviewer and self-administrations by independent t test
Unadjusted and adjusted mean differences in FACT-C subscales between modes of administration
| Mean difference (Self- interview) | ||||||
|---|---|---|---|---|---|---|
| Unadjusted | Adjusted‡ | |||||
| Mean | 95 % CI |
| Mean | 95 % CI |
| |
| PWB*† | −2.30 | (−3.19, −1.42) | <0.001 | −2.26 | (−3.27, −1.26) | <0.001 |
| SWB | 0.17 | (−0.98, 1.31) | 0.776 | 0.49 | (−0.73, 1.71) | 0.432 |
| EWB*† | −2.39 | (−3.23, −1.56) | <0.001 | −2.20 | (−3.14, −1.25) | <0.001 |
| FWB | −0.33 | (−1.52, 0.85) | 0.583 | −0.25 | (−1.57, 1.07) | 0.707 |
| CCS*† | −1.67 | (−2.59, −0.75) | <0.001 | −1.72 | (−2.78, −0.65) | 0.002 |
*Significant difference between modes of administration by independent t test
†Significant difference between modes of administration by regression
‡Mean differences were adjusted by socio-demographic and clinical characteristics by regression
Factor loadings among two modes of administration in single-group analyses
| Subscale/item | Interview ( | Self ( | Total ( | |||
|---|---|---|---|---|---|---|
| Factor loading |
| Factor loading |
| Factor loading |
| |
| PWB | ||||||
| GP1 | 0.654 | 0.427 | 0.716 | 0.512 | 0.708 | 0.501 |
| GP2 | 0.653 | 0.426 | 0.700 | 0.491 | 0.719 | 0.516 |
| GP3 | 0.793 | 0.628 | 0.749 | 0.562 | 0.769 | 0.592 |
| GP4 | 0.520 | 0.270 | 0.723 | 0.523 | 0.657 | 0.431 |
| GP5 | 0.646 | 0.418 | 0.770 | 0.592 | 0.765 | 0.585 |
| GP6 | 0.701 | 0.491 | 0.902 | 0.814 | 0.831 | 0.690 |
| GP7 | 0.870 | 0.756 | 0.881 | 0.776 | 0.853 | 0.727 |
| SWB | ||||||
| GS1 | 0.792 | 0.627 | 0.866 | 0.751 | 0.836 | 0.699 |
| GS2 | 0.864 | 0.746 | 0.915 | 0.837 | 0.896 | 0.804 |
| GS3 | 0.840 | 0.705 | 0.859 | 0.739 | 0.838 | 0.703 |
| GS4 | 0.845 | 0.714 | 0.875 | 0.766 | 0.848 | 0.720 |
| GS5 | 0.831 | 0.691 | 0.891 | 0.794 | 0.881 | 0.777 |
| GS6 | 0.724 | 0.524 | 0.827 | 0.684 | 0.801 | 0.642 |
| EWB | ||||||
| GE1 | 0.876 | 0.767 | 0.812 | 0.659 | 0.836 | 0.698 |
| GE2 | 0.678 | 0.460 | 0.733 | 0.537 | 0.708 | 0.502 |
| GE3 | 0.842 | 0.709 | 0.904 | 0.816 | 0.891 | 0.793 |
| GE4 | 0.615 | 0.379 | 0.807 | 0.652 | 0.781 | 0.609 |
| GE5 | 0.764 | 0.584 | 0.743 | 0.553 | 0.780 | 0.608 |
| GE6 | 0.632 | 0.400 | 0.837 | 0.700 | 0.803 | 0.644 |
| FWB | ||||||
| GF1 | 0.602 | 0.363 | 0.837 | 0.701 | 0.706 | 0.498 |
| GF2 | 0.735 | 0.541 | 0.917 | 0.842 | 0.859 | 0.737 |
| GF3 | 0.843 | 0.711 | 0.902 | 0.814 | 0.883 | 0.780 |
| GF4 | 0.792 | 0.627 | 0.785 | 0.616 | 0.791 | 0.626 |
| GF5 | 0.659 | 0.434 | 0.755 | 0.569 | 0.716 | 0.513 |
| GF6 | 0.672 | 0.451 | 0.894 | 0.799 | 0.814 | 0.662 |
| GF7 | 0.802 | 0.644 | 0.869 | 0.755 | 0.848 | 0.719 |
| CCS | ||||||
| C1 | 0.715 | 0.511 | 0.651 | 0.424 | 0.689 | 0.474 |
| C2 | 0.627 | 0.393 | 0.544 | 0.296 | 0.572 | 0.328 |
| C3 | 0.467 | 0.218 | 0.690 | 0.476 | 0.623 | 0.388 |
| C4 | 0.608 | 0.370 | 0.730 | 0.532 | 0.690 | 0.477 |
| C5 | 0.303 | 0.092 | 0.398 | 0.159 | 0.412 | 0.170 |
| C6 | 0.524 | 0.275 | 0.791 | 0.625 | 0.705 | 0.496 |
| C7 | 0.758 | 0.575 | 0.818 | 0.668 | 0.787 | 0.620 |
*Goodness-of-fit of CFA model by self-administration: RMSEA = 0.072, 90 % CI = 0.066–0.077, CFI = 0.977, TLI = 0.975
†Goodness-of-fit of CFA model by interviewer administration: RMSEA = 0.065, 90 % CI = 0.057–0.073, CFI = 0.963, TLI = 0.960
‡Goodness-of-fit of CFA model: RMSEA = 0.068, 90 % CI = 0.063–0.072, CFI = 0.975, TLI = 0.973
Model fit indices summary for single-group and multiple-group comparisons
| Model type | Constraints | SB χ2 |
| RMSEA | RMSEA (90 % CI) | CFI | TLI | Model comparison | ∆SB χ2 | ∆ |
| ∆CFI |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||||
| 1. Interviewer administration | None | 799.64 | 485 | 0.0647 | (0.0566, 0.0726) | 0.963 | 0.960 | NA | NA | NA | NA | NA |
| 2. Self-administration | None | 1066.81 | 485 | 0.0716 | (0.0658, 0.0774) | 0.977 | 0.975 | NA | NA | NA | NA | NA |
|
| ||||||||||||
| 3. Full configural invariance | Factor structure | 1804.21 | 970 | 0.0665 | (0.0617, 0.0712) | 0.962 | 0.958 | NA | NA | NA | NA | NA |
| 4. Full metric invariance | Factor structure, factor loadings | 1837.51 | 998 | 0.0658 | (0.0610, 0.0705) | 0.962 | 0.959 | 3 vs 4 | 33.29 | 28 | 0.225 | 0.000 |
| 5. Full scalar invariance | Factor structure, factor loadings, intercepts | 1964.54 | 1026 | 0.0686 | (0.0640, 0.0731) | 0.957 | 0.956 | 3 vs 5 | 127.04 | 28 | 0.000 | -0.005 |
| 6. Partial scalar invariance | Factor structure, factor loadings, intercepts (GF1, GP3, GS3 freely estimated) | 1862.34 | 1023 | 0.0649 | (0.0603, 0.0696) | 0.962 | 0.960 | 4 vs 6 | 24.83 | 25 | 0.472 | 0.000 |
| 7. Partial strict factorial invariance | Factor structure, factor loadings, intercepts (GF1, GP3, GS3 freely estimated), error variance (GF1, GP3, GS3 freely estimated) | 1839.99 | 1053 | 0.0620 | (0.0573, 0.0667) | 0.964 | 0.964 | 6 vs 7 | 22.35 | 30 | 0.841 | 0.002 |
SB Satorra–Bentler, df degree of freedom, RMSEA root mean square error of approximation, CFI comparative fit index, TLI Tucker–Lewis index